GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,339 | -8.5% | 43,802 | +3.7% | 0.00% | -100.0% |
| Q2 2023 | $82,378 | -5.3% | 42,245 | +99.2% | 0.00% | – |
| Q1 2022 | $87,000 | -70.2% | 21,212 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $292,000 | +22.2% | 22,706 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $239,000 | +15.5% | 22,100 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $207,000 | +25.5% | 22,626 | +29.0% | 0.00% | 0.0% |
| Q1 2021 | $165,000 | +139.1% | 17,545 | +0.3% | 0.00% | – |
| Q4 2020 | $69,000 | +43.8% | 17,499 | -2.8% | 0.00% | – |
| Q3 2020 | $48,000 | -60.3% | 18,000 | -1.0% | 0.00% | -100.0% |
| Q2 2020 | $121,000 | +40.7% | 18,174 | +23.2% | 0.00% | – |
| Q1 2020 | $86,000 | -38.6% | 14,753 | -5.5% | 0.00% | -100.0% |
| Q4 2019 | $140,000 | +2.9% | 15,605 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $136,000 | -23.2% | 15,736 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $177,000 | +200.0% | 15,846 | +259.2% | 0.00% | – |
| Q1 2019 | $59,000 | -15.7% | 4,412 | -3.1% | 0.00% | – |
| Q4 2018 | $70,000 | – | 4,555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |